CTOs on the Move

Oramed

www.oramed.com

 
Oramed Pharmaceuticals (Nasdaq/TASE: ORMP) is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD™) technology. Oramed is seeking to transform the treatment of diabetes through its proprietary lead candidate, ORMD-0801, which is being evaluated in two pivotal Phase 3 studies and has the potential to be the first commercial oral insulin capsule for the treatment of diabetes. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule (ORMD-0901).
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.oramed.com
  • 1185 Avenue of the Americas 3rd Floor
    New York, NY USA 10036
  • Phone: 646.844.1164

Executives

Name Title Contact Details

Funding

Oramed raised $50M on 11/03/2021

Similar Companies

Lutheran Social Services of Southern California

Amgenix International

Amgenix International is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Porzio Life Sciences

Regulatory compliance software solutions, products and services assist pharmaceutical, medical device and biotechnology companies in complying with marketing and sales regulations.

Nucryst Pharmaceuticals

Nucryst Pharmaceuticals Corp. is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Organon

Organon is a West Orange, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.